Harvard Stem Cell Institute-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Harvard Stem Cell Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013950
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Harvard Stem Cell Institute (HSCI), a subsidiary of Harvard University is a healthcare institute that conducts research on advance stem cell science using stem cell biology to develop new treatments and cures for disease. The institute provides research programs such as disease programs, core facilities, early-stage research, MD and PhD fellowship, and internship program. It undertakes various disease research programs, which include blood program, cardiovascular program, cancer program, diabetes program, kidney program, nervous system diseases program, and translation research program. The institute also offers clinical trial services. HSCI is headquartered in Cambridge, Massachusetts, the US.

Harvard Stem Cell Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Thrive Bioscience and Harvard Stem Cell Institute Enter into Agreement 10
Boehringer Ingelheim Enters into Research Agreement with Harvard Stem Cell Institute 11
AstraZeneca Enters into Research Agreement with Harvard Stem Cell Institute 12
Evotec Enters Into Research Agreement With Harvard Stem Cell Institute For Amyotrophic Lateral Sclerosis 13
Harvard Stem Cell Institute – Key Competitors 14
Harvard Stem Cell Institute – Key Employees 15
Harvard Stem Cell Institute – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Government and Public Interest 17
Aug 04, 2016: Researchers from CSI Singapore discover new way to inhibit development of lung cancer 17
Jun 06, 2016: New approach could make bone marrow transplants safer 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Key Facts 2
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Harvard Stem Cell Institute, Deals By Therapy Area, 2011 to YTD 2017 8
Harvard Stem Cell Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Thrive Bioscience and Harvard Stem Cell Institute Enter into Agreement 10
Boehringer Ingelheim Enters into Research Agreement with Harvard Stem Cell Institute 11
AstraZeneca Enters into Research Agreement with Harvard Stem Cell Institute 12
Evotec Enters Into Research Agreement With Harvard Stem Cell Institute For Amyotrophic Lateral Sclerosis 13
Harvard Stem Cell Institute, Key Competitors 14
Harvard Stem Cell Institute, Key Employees 15

★海外企業調査レポート[Harvard Stem Cell Institute-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Innergex Renewable Energy Inc (INE):企業の財務・戦略的SWOT分析
    Innergex Renewable Energy Inc (INE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Alfa Group Consortium:企業の戦略的SWOT分析
    Alfa Group Consortium - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Obalon Therapeutics Inc (OBLN):製薬・医療:M&Aディール及び事業提携情報
    Summary Obalon Therapeutics Inc (Obalon Therapeutics) is a manufacturer of medical devices and equipment. The company offers development and commercializing medical devices to treat obese and overweight people by facilitating weight loss. It also researches, designs, produces, and sells medical gast …
  • NicOx SA (COX):企業の財務・戦略的SWOT分析
    Summary Nicox SA is an ophthalmology company developing solutions to help maintain vision and improve ocular health. The company is engaged in the research, development and marketing investigational drugs for ophthalmological diseases. The aims to produce therapeutic products which aims to address t …
  • Hub International Limited:企業のM&A・事業提携・投資動向
    Hub International Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hub International Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Disco Corp (6146):企業の財務・戦略的SWOT分析
    Disco Corp (6146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Iberdrola SA (IBE):企業の財務・戦略的SWOT分析
    Iberdrola SA (IBE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Temple University-製薬・医療分野:企業M&A・提携分析
    Summary Temple University (Temple) is an educational and research university that offers undergraduate and graduate courses. The university offers undergraduate courses in various fields which include arts, media and communication, medicine, engineering, pharmacy and others. Temple offers its degree …
  • Tocardo International BV:電力:M&Aディール及び事業提携情報
    Summary Tocardo International BV (Torcado), a subsidiary of Tribute Resources Inc, is an energy equipment provider that manufactures and markets offshore turbines. The company offers wind turbines, sea defences, commercial demonstrator and others. It also offers river and tidal turbines. Torcado’s p …
  • LineStar Integrity Services LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary LineStar Integrity Services LLC (LineStar) is an oil and gas company that provides integrated solutions. The company provides services such as integrity maintenance, measurement and automation, construction services, and others. It offers measurement and automation services such as pipeline …
  • Shanghai Kehua Bio-engineering Co Ltd (002022)-医療機器分野:企業M&A・提携分析
    Summary Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits and labor …
  • Norwegian Energy Company ASA (NOR):企業の財務・戦略的SWOT分析
    Summary Norwegian Energy Company ASA (Noreco) is an oil and gas company that offers exploration and development services. The company explores, produces and develops oil, gas, and natural gas liquids deposit properties. It operates through ongoing and planned exploration wells such as PL616 Haribo a …
  • Samart Corporation Plc (SAMART):企業の財務・戦略的SWOT分析
    Samart Corporation Plc (SAMART) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Aduro BioTech Inc (ADRO):製薬・医療:M&Aディール及び事業提携情報
    Summary Aduro BioTech Inc (Aduro BioTech) is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sti …
  • Malaysia Airlines Berhad:戦略・SWOT・企業財務分析
    Malaysia Airlines Berhad - Strategy, SWOT and Corporate Finance Report Summary Malaysia Airlines Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • KemPharm Inc (KMPH):製薬・医療:M&Aディール及び事業提携情報
    Summary KemPharm Inc (KemPharm) is a clinical-stage specialty pharmaceutical company that offers discovery and development of proprietary new molecular entity prodrugs. The company’s product pipeline includes KP415, methylphenidate drug for ADHD; KP201/IR, KP511/ER, KP606/IR and KP746 drugs for the …
  • Allison Transmission Holdings Inc:企業の戦略・SWOT・財務情報
    Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Allison Transmission Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • ContraVir Pharmaceuticals Inc (CTRV):企業の財務・戦略的SWOT分析
    Summary ContraVir Pharmaceuticals Inc (ContraVir) is a biopharmaceutical company that offers development and commercialization of targeted antiviral therapies. The company provides pipeline product such as TXL, potent prodrug of antiviral tenofovir and CRV431 cyclophilin inhibitor that increases its …
  • Placon Corporation:企業の戦略・SWOT・財務情報
    Placon Corporation - Strategy, SWOT and Corporate Finance Report Summary Placon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • The Miyazaki Bank Ltd.:企業の戦略・SWOT・財務情報
    The Miyazaki Bank Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Miyazaki Bank Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆